搜尋結果
COVID shots should target JN.1 variant in 2024-25 campaign, US FDA says
Reuters· 11 小時前The U.S. Food and Drug Administration on Friday advised COVID-19 vaccine manufacturers ... ...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 22 小時前Firstly, the U.S. FDA recently approved Moderna’s respiratory syncytial virus vaccine, making ...
How 1301B7 Could Contribute To Advanced Vaccine Development
Forbes· 22 小時前In the ongoing Omicron era, a new COVID-19 antibody could renew optimism for urgently required ...